Co-administration of AAI with probenecid or rhein, inhibitors of both OAT1 and OAT3 (Ma et al., 2014), can reduce AAI accumulation in the kidney and protect the kidneys against AAN (Sekine et al., 2000; Shibutani et al., 2007). The gene discussed is SLC22A6; the disease is Balkan nephropathy.